Initial Prior Authorization with Quantity Limit Zepbound Weight Loss Management
Customize your policy alerts
Sign up for cvs_caremark Policy 6192-C alerts
Get alerted when Policy 6192-C changes without checking for updates manually.
Monitor payer policy activity
This policy governs initial and continuation prior authorization, quantity limits, and approval durations for Zepbound (tirzepatide) in adults with obesity or overweight-related weight management needs and adults with obesity and moderate to severe obstructive sleep apnea. Coverage requires specified clinical criteria, documentation, reduced-calorie diet, and increased physical activity.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.